Identification of men with the highest risk of early disease recurrence after radical prostatectomy

Prostate

Volumn 74, Issue 6, 2014, Pages 628-636

  Sundi, Debasish ^a   Wang, Vinson ^a   Pierorazio, Phillip M ^a   Han, Misop ^a   Partin, Alan W ^a   Tran, Phuoc T ^a   Ross, Ashley E ^a   Bivalacqua, Trinity J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

early biochemical recurrence; intraoperative therapy; multimodal therapy; prostate cancer

Indexed keywords

ADULT; AFRICAN AMERICAN; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CAUCASIAN; COHORT ANALYSIS; DISTANT METASTASIS; FEMALE; FOLLOW UP; GLEASON SCORE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PERINEURAL INVASION; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SURGICAL RISK;

EARLY BIOCHEMICAL RECURRENCE; INTRAOPERATIVE THERAPY; MULTIMODAL THERAPY; PROSTATE CANCER;

AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK; TREATMENT OUTCOME;

EID: 84897028763     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22780     Document Type: Article

References (21)

1. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A,. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280 (11): 969-974.
2. Yuh B, Artibani W, Heidenreich A, Kimm S, Menon M, Novara G, Tewari A, Touijer K, Wilson T, Zorn KC, Eggener SE,. The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: A systematic review. Eur Urol 2013; 1-10.
3. Loeb S, Schaeffer EM, Trock BJ, Epstein JI, Humphreys EB, Walsh PC,. What are the outcomes of radical prostatectomy for high-risk prostate cancer ? Urology 2010; 76 (3): 710-714.
4. Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Colombel M, van de Beek C, Verhagen P, van den Bergh A, Sternberg C, Gasser T, vanTienhoven G, Scalliet P, Haustermans K, Collette L,. Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Lancet 2005; 366 (9485): 572-578.
5. Van der Kwast TH, Bolla M, Van Poppel H, Van Cangh P, Vekemans K, Da Pozzo L, Bosset JF, Kurth KH, Schroder FH, Collette L,. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol 2007; 25 (27): 4178-4186.
6. Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED,. Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial. JAMA 2006; 296 (19): 2329-2335.
7. Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED,. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial. J Urol 2009; 181 (3): 956-962.
8. Wiegel T, Bottke D, Steiner U, Seigmann A, Golz R, Storkel S, Willich N, Semjonow A, Souchon R, Stockle M, Rube C, Weissbach L, Althaus P, Rebmann U, Kalble T, Feldmann HJ, Wirth M, Hinke A, Hinkelbein W, Miller K,. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 2009; 27 (18): 2924-2930.
9. Rocco B, Jereczek-Fossa B, Matei DV, Verweij F, Santoro L, Vavassori A, Ospina JC, Cedeira F, Ciocca M, Orecchia R,., de Cobelli O,. Intraoperative radiotherapy during radical prostatectomy for intermediate-risk to locally advanced prostate cancer: Treatment technique and evaluation of perioperative and functional outcome vs standard radical prostatectomy, in a matched-pair analysis. BJU Int 2009; 104 (11): 1624-1630.
10. Krengli M, Terrone C, Jereczek-Fossa BA, Beldì D, Orecchia R,. May intra-operative radiotherapy have a role in the treatment of prostate cancer ? Crit Rev Oncol Hematol 2012; 83 (1): 123-129.
11. Trock BJ, Han M, Freedland SJ, Humphreys EB, DeWeese TL, Partin AW, Walsh PC,. Prostate cancer-specific survival following salvage radiotherapy vs observation after radical prostatectomy. JAMA 2008; 299 (23): 2760-2769.
12. Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JK, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti RK, Kuban KA, Pollack A,. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007; 25 (15): 2035-2041.
13. Swanson GP, Hussey MA, Tangen CM, Chin J, Messing E, Canby-Hagino E, Forman JD, Thompson IM, Crawford ED,. Predominant treatment failure in postprostatectomy patients is local: Analysis of patterns of treatment failure in SWOG 8794. J Clin Oncol 2007; 25 (16): 2225-2229.
14. Bivalacqua TJ, Pierorazio PM, Gorin MA, Allaf ME, Carter HB, Walsh PC,. Anatomic extend of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy. Urology 2013; 82 (3): 653-659.
15. NCCN. Clinical practice guidelines in oncology: Prostate cancer. National comprehensive cancer network. 2012; Version 3. Available at: NCCN.org.
16. Epstein JI, Allsbrook WC, Amin MB, Egevad LL,. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29 (9): 1228-1242.
17. Abdollah F, Suardi N, Cozzarini C, Gallina A, Capitanio U, Bianchi M, Sun M, Fossati N, Passoni NM, Fiorino C, Di Muzio N, Karakiewicz PI, Rigatti P, Montorsi F, Briganti A,. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: A long-term survival analysis. Eur Urol 2013; 63 (6): 998-1008.
18. Bolla M,. Adjuvant or immediate external irradiation after radical prostatectomy with pelvic lymph node dissection for high-risk prostate cancer: A multidisciplinary decision. Eur Urol 2013; 63 (6): 1009-1010.
19. Borque A, Del Amo J, Esteban LM, Ars E, Hernandez C, Planas J, Arruza A, Llarena R, Palou J, Herranz F, Raventos CX, Tejedor D, Artieda M, Simon L, Martinez A, Carceller E, Suarez M, Allue M, Sanz G, Morote J,. Genetic predisposition to early recurrence in clinically localized prostate cancer. BJU Int 2013; 111 (4): 549-555.
20. Coen JJ, Zietman AL, Thakral H, Shipley WU,. Radical radiation for localized prostate cancer: Local persistence of disease results in a late wave of metastases. J Clin Oncol 2002; 20 (15): 3199-3205.
21. Shukla-Dave A, Hricak H, Akin O, Yu C, Zakian KL, Udo K, Scardino PT, Eastham J, Kattan MW,. Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. BJU Int 2012; 109 (9): 1315-1322.